uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences. (Hematologi)
Show others and affiliations
2007 (English)In: Medical Oncology, ISSN 1357-0560, E-ISSN 1559-131X, Vol. 24, no 3, 267-272 p.Article in journal (Refereed) Published
Abstract [en]

Due to concerns related to treatment with erythropoietin (EPO) and possible negative effects on tumour control, a workshop was organised by the Medical Products Agency of Sweden with the aim to revise national treatment guidelines if needed. In patients with solid tumours, conflicting results have been reported with respect to tumour control and survival. Until further notice it is therefore recommended that EPO should be used restrictively in the treatment of patients with cancer and that the anticipated improvement in quality of life should be evaluated against potential risks.

Place, publisher, year, edition, pages
2007. Vol. 24, no 3, 267-272 p.
Keyword [en]
Anemia, Cancer therapy, Epoetin, Erythropoietin, Erythropoietin receptor, Safety
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-13205DOI: 10.1007/s12032-007-0037-5ISI: 000249339900001PubMedID: 17873301OAI: oai:DiVA.org:uu-13205DiVA: diva2:40975
Available from: 2008-01-22 Created: 2008-01-22 Last updated: 2011-01-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Medical Sciences
In the same journal
Medical Oncology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 208 hits
ReferencesLink to record
Permanent link

Direct link